Rob Surgical has announced today the completion of the second series of surgeries that it was carrying out at the Hospital Clínic of Barcelona, with whom it has a collaboration agreement in the field of Urology. With this new milestone, the technology company faces the final phase of European certification.
In this new series, surgeries have been performed on living patients, performing partial and radical nephrectomies and radical prostatectomy, thus expanding the scope of clinical studies of the Bitrack surgical robot and increasing the collection of data on real cases.
The achievement of these operations allows us to continue advancing and expanding the scope of the robot’s usefulness, with the aim of covering all the needs of Urology and extending its use to other specialties.
The surgeons Dr. Lluís Peri and Dra. Mireia Musquera, specialists from the Urology Service led by Dr. Antonio Alcaraz, have carried out the surgeries in this new study.
This new milestone is one more step towards the company’s purpose; universalize precision surgery to make it accessible to all hospitals, surgeons and patients in the world. Furthermore, the close alliance between Rob Surgical and the Hospital Clínic of Barcelona promotes the consolidation of precision surgery in the field of Urology. It is an achievement that will allow all patients in this area to benefit from the advantages of precision surgery.
